Not available.
Not affordable.
Not anymore.
Send us the prescription your doctor wrote. We source it from licensed manufacturers and send you a price before you pay anything.
Certified at source
Every product is sourced from a facility certified to WHO-GMP, US FDA, UK MHRA, EMA, PIC/S or WHO-PQ standards — checked before we'll buy, not after a problem appears.
See the twelve manufacturer standardsA prescription, every time
No patient order ships without a valid prescription from the patient's own doctor. No exceptions, for anyone, at any volume.
How ordering worksAccountable in public
An Active Participant of the UN Global Compact since 4 November 2024, with two Communications on Progress filed and readable by anyone.
What that commits us to
Because every cancer journey deserves care.
What institutional buyers get
beyond the product
The full twelve-point standard, and terms for hospitals and distributors
Hospitals and distributors aren't really buying a molecule. They're buying someone else's due diligence, and the confidence that it will hold up when their regulator, their pharmacy team, or their patient asks.
A network vetted before you buy
Twelve separate standards — certifications, documented quality history, production capacity, dossier completeness, cold-chain validation — applied before we'll source from a manufacturer, not after something goes wrong.
Documentation ready before you ask
Certificates of Analysis, stability data and batch records prepared ahead of the shipment, so your regulatory or pharmacy team isn't chasing paperwork after the consignment has landed.
Cold chain that's actually validated
Documented cold storage and transport for biologics, biosimilars and other temperature-sensitive product, with handling records that travel with the goods.
A named team, not a queue
One point of contact through sourcing, documentation, freight and afterwards — including when the honest answer is that we can't meet a timeline.
India is the base, not the boundary
India manufactures more of the world's generic medicine than any other country, which is why we're headquartered here. But the right manufacturer for a molecule isn't always in the same country as the last one, so the network extends beyond it: EMA and UK MHRA-certified specialty products from Europe, FDA-approved biologics and specialty therapies from the United States, and selective partnerships elsewhere for specific therapeutic areas.
What stays constant across all of them is the standard applied before a manufacturer joins the network at all.
Sourcing regions, dossier support and distributorship terms in full
Where We Source From
🇮🇳 India
Home to the world's largest generic pharmaceutical manufacturers.
🇪🇺 Europe
UK MHRA and EMA-certified specialty pharmaceutical products.
🇺🇸 United States
FDA-approved specialty therapies and biologics.
Other Regions
Strategic partnerships for specific therapeutic areas.
Our Pharmaceutical Portfolio
Our catalogue is built around the therapies where supply fails most often and the consequences are worst — oncology and hematology first, then the anti-infectives, biologics and critical-care lines a hospital cannot run without. Every category below is sourced against the same manufacturer standard.
View AllWhen Treatment Matters,
Supply Matters.
Oncology is where a supply chain's weaknesses surface fastest. The products are specialised, often temperature-sensitive, frequently unregistered in exactly the markets where the need is greatest — and a missed cycle isn't a late delivery, it's a clinical event.
We source oncology, hematology and specialty supply against that reality, including medicines not yet registered locally, coordinated at a physician's request through licensed importers and hospitals, for the specific patient who needs them.
Behind every oncology shipment is a healthcare need.
Why India as Our Export Hub
India produces more of the world's generic medicine than anywhere else. That single fact is why the same molecule, made to the same standard, can cost very differently depending on where it's sourced — and it's why we're based here.
Scale that changes the price
Manufacturing depth, not discounting, is what makes a medicine priced out of reach in one market affordable when sourced from another.
+Certifications your regulator recognises
Facilities in our network hold WHO-GMP, US FDA, UK MHRA, EMA, PIC/S and WHO-PQ approvals — the same marks hospital pharmacies and regulators already look for.
+Relationships, not spot buys
We work with a selected set of manufacturers over time rather than buying whatever is cheapest that week. That is the difference between supply being predictable and being opportunistic.
+Routes that protect the product
India's position on major trade lanes supports export to Asia-Pacific, Africa, Latin America and the Middle East without transit times that put temperature-sensitive product at risk.
+Documentation prepared here
Our team prepares and coordinates the export documentation each destination market requires, so paperwork isn't what holds the shipment at a border.
+
When the medicine exists and still doesn't reach you
A prescription from your own doctor. A check that the medicine can legally reach your country. One price, in writing, before you commit to anything. And if we can't legally reach you, we say so plainly instead of taking the order anyway.
How ordering works, step by stepGlobal Pharmaceutical Partner
From certified manufacturers to hospitals, importers and distributors across Asia-Pacific, the Middle East, Africa and Latin America — one standard applied to every shipment, whatever its destination and whoever is receiving it.
What that standard commits us to publicly, including our UN Global Compact participation, is set out in full on our Sustainability page.
Sustainability & SDGsFeatured Articles
Explore our latest research, regulatory updates, and industry insights in global pharmaceutical distribution.
First Affordable Teriparatide Injection Biosimilar Will Enter the Philippine Market
Getmeds, a trusted provider of affordable cancer, hematology, and anesthesia products, is taking a meaningful step forward by offering the most cost-effective teriparatide injection pen biosimilar in the Philippine market.
How to Get Medical Assistance from DSWD: Your 2025 Ultimate Guide
Ang Kagawaran ng Kagalingan at Pagpapaunlad Panlipunan o Department of Social Welfare and Development (DSWD) ay isang ahensya ng gobyerno na namamahala sa pagbuo, pagtupad, at pag-coordinate ng mga…
9 Affordable and Healthy Filipino Foods That Help Reduce Cancer Risk Budget Friendly Alternatives
More than being physically fit and keeping your body in shape, ensuring that you’re eating healthy with cancer-fighting food as you’re undergoing chemotherapy and taking other prescribed cancer medicines is beneficial for the entirety of your well-being.
Getmeds Salute Cancer Warriors: Free Live Q&A with a Doctor This April – Get Your Questions Answered!
Las Pinas City, Philippines — With its ongoing support for cancer patients and the importance of making healthcare information accessible to all, Getmeds Philippines Inc. invites you to a free virtual question and answer for cancer patients to be held this April 2025.
Life-Changing Tips for Managing Chemotherapy Side Effects in 2025: What to Do Before, During, and After Treatment
Chemotherapy side effects may vary from person to person, but there are a couple of common ones that patients often always get to experience as they’re taking their cancer care medicines or undergoing their cancer treatments.
Getmeds Healthcare connects certified manufacturers with healthcare partners worldwide, delivering reliable pharmaceutical exports at every step.
Learn more